These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7410529)

  • 1. Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression.
    Carroll BJ; Schroeder K; Mukhopadhyay S; Greden JF; Feinberg M; Ritchie J; Tarika J
    J Clin Endocrinol Metab; 1980 Sep; 51(3):433-7. PubMed ID: 7410529
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
    Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
    J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cortisol suppression index and the dexamethasone suppression test in major depression.
    Maes M; De Ruyter M; Suy E
    Acta Psychiatr Belg; 1987; 87():633-9. PubMed ID: 3452982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R; Barocka A; Pichl J
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.
    Syvälahti E; Hyyppä MT; Salminen JK
    Ann Clin Res; 1985; 17(4):148-51. PubMed ID: 4073803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dexamethasone suppression test in endogenous depression and schizophrenia in male and female patients].
    Płocka M; Matkowski K; Lehmann W; Kanarkowski R; Rybakowski J
    Psychiatr Pol; 1992; 26(5):373-80. PubMed ID: 1302336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dexamethasone suppression test in hospitalized patients with major depressive and other psychiatric disorders].
    Miró Aguadé E; Fernández Logroño J; Bonnin MR; Muruamendiaraz Bastarrika JR
    Med Clin (Barc); 1984 Feb; 82(4):149-51. PubMed ID: 6708621
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses.
    Grady JA; Davis EG; Kukanich B; Sherck AB
    Am J Vet Res; 2010 Jul; 71(7):831-9. PubMed ID: 20594087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The low-dose dexamethasone suppression test in fibromyalgia.
    Wingenfeld K; Wagner D; Schmidt I; Meinlschmidt G; Hellhammer DH; Heim C
    J Psychosom Res; 2007 Jan; 62(1):85-91. PubMed ID: 17188125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cortisol response to dexamethasone suppression in depressed and control patients.
    Shopsin B; Gershon S
    Arch Gen Psychiatry; 1971 Apr; 24(4):320-6. PubMed ID: 4323948
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous determination of prednisone, prednisolone, cortisol and dexamethasone in plasma by high-performance liquid chromatography.
    Lasić S; Bobarević N; Nikolin B
    J Pharm Biomed Anal; 1989; 7(6):777-82. PubMed ID: 2490780
    [No Abstract]   [Full Text] [Related]  

  • 16. Cortisol and dexamethasone elimination during treatment with cimetidine.
    Peden NR; Rewhorn I; Champion MC; Mussani R; Ooi TC
    Br J Clin Pharmacol; 1984 Jul; 18(1):101-3. PubMed ID: 6743481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent pharmacokinetics of dexamethasone.
    Loew D; Schuster O; Graul EH
    Eur J Clin Pharmacol; 1986; 30(2):225-30. PubMed ID: 3709651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial postdexamethasone cortisol levels in a patient undergoing ECT.
    Dysken MW; Pandey GN; Chang SS; Hicks R; Davis JM
    Am J Psychiatry; 1979 Oct; 136(10):1328-9. PubMed ID: 484732
    [No Abstract]   [Full Text] [Related]  

  • 19. False normal dexamethasone suppression test and indomethacin.
    Mathé AA
    Lancet; 1982 Sep; 2(8300):714. PubMed ID: 6126646
    [No Abstract]   [Full Text] [Related]  

  • 20. The dexamethasone suppression test as a diagnostic aid in catatonia.
    Greden JF; Carroll BJ
    Am J Psychiatry; 1979 Sep; 136(9):1199-200. PubMed ID: 474811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.